Production (Stage)
Yubo International Biotech Limited
YBGJ
$0.0612
$0.015233.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.45% | 44.01% | -9,319.05% | -43.62% | -19.13% |
| Total Depreciation and Amortization | -4.09% | -63.16% | 2.76% | 151.37% | 384.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.55% | -- | 86.29% | -60.02% | -- |
| Change in Net Operating Assets | -5.25% | -296.09% | 40.49% | 163.28% | -88.19% |
| Cash from Operations | -18.57% | -67.03% | -1,915.69% | -25.49% | -911.01% |
| Capital Expenditure | 67.20% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 79.33% | -- | -- | -- | -- |
| Total Debt Issued | 32.16% | 38.47% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9.86% | 48.77% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 19.50% | 4.56% | 722.00% | -212.27% | 130.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.48% | -190.91% | 200.00% | -97.20% | 322.50% |